Please assess the completion status of the following clinical trial:

Trial Title: Cytokine Profiling Post-Heart Transplant

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Group 1~* 18 years and older~* Cardiac Transplant recipient with graft dysfunction of unknown etiology~Group 2~* 18 years or older~* No history of heart failure or cardiac transplantation Group 3~* 18 years or older~* Class II-IV heart failure Group 4~* 18 years or older~* Heart Transplant 6 months or greater prior to blood draw~* No graft dysfunction~Exclusion Criteria:~Group 1 Heart Transplant with Unexplained Graft Dysfunction~* Cellular or antibody-mediated cardiac allograft dysfunction~Group 2 Normal Control group~* Active infection within 1 month of blood draw~* Known Inflammatory Disease~Group 3 Heart Failure Group~* Active infection within 1 month of blood draw~* Known Inflammatory Disease~Group 4 Heart Transplant with Normal Graft Function Group~* Active infection within 1 month of blood draw~* Known graft dysfunction~* Known Inflammatory Disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Group 1 (Type: None): Heart Transplant Recipients with Unexplained Graft Dysfunction
- Group 2 (Type: None): Normal Control
- Group 3 (Type: None): Class III-IV Heart Failure
- Group 4 (Type: None): Heart Transplant Recipients with Normal Graft Function

Based on this trial design, predict the completion outcome and termination type (if applicable).